Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion type Assertion NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_head.
- NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion description "[Vascular endothelial growth factor (VEGF)-based gene therapy protocols have been used to treat tissue ischemia, and a combined VEGF/MSC therapeutics is appealing due to their synergistic paracrine actions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_provenance.
- NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion evidence source_evidence_literature NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_provenance.
- NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion SIO_000772 18288639 NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_provenance.
- NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion wasDerivedFrom befree-20140225 NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_provenance.
- NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_assertion wasGeneratedBy ECO_0000203 NP770166.RAEC21XKEPaP0-3AX-GePjLVfGbOtOfA8TisrzIw6Gv0c130_provenance.